ZKF-J67 (M5): Metabolic Reprogramming as a Gatekeeper for Induction/Function of Myeloid Derived Suppressor Cells in AML

FAU own research funding: EFI / IZKF / EAM ...

Start date : 01.01.2018

End date : 30.06.2021

Overview

Publications

(3)

Palmitoylated Proteins on AML-Derived Extracellular Vesicles Promote Myeloid-Derived Suppressor Cell Differentiation via TLR2/Akt/mTOR Signaling (2020) Tohumeken S, Böttcher M, Stoll A, Loschinski R, Panagiotidis K, Braun M, Saul D, et al. Journal article Inflammation-induced glycolytic switch controls suppressivity of mesenchymal stem cells via STAT1 glycosylation (2019) Jitschin R, Böttcher M, Saul D, Lukassen S, Bruns H, Loschinski R, Ekici AB, et al. Journal article CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells (2018) Jitschin R, Saul D, Braun M, Tohumeken S, Kischel R, Lutteropp M, Dos Santos C, et al. Journal article